Strategic Expansion CGT Global has a national footprint of clinics and laboratories and partnerships with over 40 hospitals, presenting a sales opportunity to provide ancillary services, supply chain management, and logistics support for scale-up in new regions or care networks.

Last Mile Access The company emphasizes traversing the last mile to patient access, highlighting a need for integrated solutions in regulatory compliance, training, and in-house infusion capabilities—ideal for partnerships offering end-to-end delivery and patient support programs.

Board Advisory Recent additions to the board of advisors focused on policy and market access indicate potential collaboration avenues in policy navigation, reimbursement strategy, and market access consulting services to accelerate therapy adoption.

Clinical and Commercial Synergy CGT Global combines research support with commercialization, creating opportunities to cross-sell services like donor tissue supply, autologous/allogeneic processing, and logistics optimization to pharmaceutical companies and research institutions.

Growing Revenue With reported revenue in the mid single-digit tens of millions and strategic partnerships established, there is potential to propose scalable, high-margin services such as turnkey cell processing, storage, and infusion operations for expanding therapy pipelines.